27.51
08-October-24 14:59:52
15 minutes delayed
Stocks
+1.51
+5.81%
Today's range
25.58 - 27.70
ISIN
N/A
Source
NASDAQ
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
25 Sep 2024 06:08:51 By Nasdaq GlobeNewswire
Oruka Therapeutics Announces $200 Million Private Placement
12 Sep 2024 06:05:00 By Nasdaq GlobeNewswire
Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
12 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
03 Sep 2024 06:00:00 By Nasdaq GlobeNewswire